Molecules:超声微泡能够增强胰岛素样生长因子-1疗法治疗噪声诱发听力损失的效果

2021-07-15 AlexYang MedSci原创

内耳是一个脆弱的感觉器官,负责听力和平衡。在成年哺乳动物中,由于耳蜗毛细胞没有再生能力,对耳蜗的损害往往导致永久性的听力损失。因此,及时和有效的疗法在内耳疾病中对实现更好的听力恢复起着关键作用。耳内给

内耳是一个脆弱的感觉器官,负责听力和平衡。在成年哺乳动物中,由于耳蜗毛细胞没有再生能力,对耳蜗的损害往往导致永久性的听力损失。因此,及时和有效的疗法在内耳疾病中对实现更好的听力恢复起着关键作用。耳内给药通常用来治疗一些听力和前庭疾病。

将胰岛素样生长因子1(IGF-1)应用于圆窗膜(RWM)是一种新兴的内耳疾病治疗方法。RWM的渗透性是高效输送IGF-1的关键因素。超声微泡(USMBs)可以增加药物通过RWM的渗透性。

近期,有研究人员调查了USMBs对IGF-1疗效的增强作用,以及USMB介导的IGF-1输送对噪声诱发听力损失(NIHL)的治疗效果

研究包括了47只豚鼠,并分配到三个小组:USM组,在RWM使用USMBs后进行重组人IGF-1(rhIGF-1,10?g/?L)的局部治疗;RWS组,单独进行IGF-1治疗;以及盐水处理组。结果发现,治疗后2小时和24小时,USM组的rhIGF-1的淋巴周围浓度分别是RWS组的1.95和1.67倍。在118 dB SPL噪音暴露5小时后,USM组的听觉脑干反应的阈值变动最低,耳蜗外毛细胞的损失最小,在暴露后第28天突触带的数量减少最少。USMB和IGF-1的组合能够使NIHL的治疗反应更好。治疗两小时后,USM组的Akt1和Mapk3基因表达水平明显高于其他两组。在USM组的耳蜗中检测到了最强烈的磷酸-AKT和磷酸-ERK1/2的免疫染色。

有无超声微泡时IGF-1在周围淋巴液中的浓度

综上所述,USMB可用于提高IGF-1疗法在治疗内耳疾病方面的疗效

原始出处:

Yi-Chun Lin, Yuan-Yung Lin, Hsin-Chien Chen et al. Ultrasound Microbubbles Enhance the Efficacy of Insulin-Like Growth Factor-1 Therapy for the Treatment of Noise-Induced Hearing Loss. Molecules. Jun 2021

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1750235, encodeId=47821e50235e1, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Nov 04 21:54:28 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809831, encodeId=e55c1809831c2, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Sat Apr 02 10:54:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034587, encodeId=ba89203458eed, content=<a href='/topic/show?id=195d83889d2' target=_blank style='color:#2F92EE;'>#胰岛素样生长因子-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83889, encryptionId=195d83889d2, topicName=胰岛素样生长因子-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Sep 19 05:54:28 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306682, encodeId=98de1306682a8, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518080, encodeId=8dda15180805e, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614164, encodeId=dc7d1614164ea, content=<a href='/topic/show?id=35fd506241c' target=_blank style='color:#2F92EE;'>#微泡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50624, encryptionId=35fd506241c, topicName=微泡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae519505912, createdName=124987cdm32暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620390, encodeId=814a16203908f, content=<a href='/topic/show?id=90c84034554' target=_blank style='color:#2F92EE;'>#噪声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40345, encryptionId=90c84034554, topicName=噪声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afc220104173, createdName=xinmeili, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000120, encodeId=2e84100012004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/3da0b4e87d244fc8964a8bc9c1f7d3b8/e4798d77bda342298fe093b744b40344.jpg, createdBy=e2623291388, createdName=Avigo, createdTime=Fri Jul 16 20:11:10 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047396, encodeId=e1d1104e3960e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 16 00:54:28 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999887, encodeId=e0fa99988e15, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Jul 15 23:12:19 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
    2021-11-04 baoya
  2. [GetPortalCommentsPageByObjectIdResponse(id=1750235, encodeId=47821e50235e1, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Nov 04 21:54:28 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809831, encodeId=e55c1809831c2, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Sat Apr 02 10:54:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034587, encodeId=ba89203458eed, content=<a href='/topic/show?id=195d83889d2' target=_blank style='color:#2F92EE;'>#胰岛素样生长因子-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83889, encryptionId=195d83889d2, topicName=胰岛素样生长因子-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Sep 19 05:54:28 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306682, encodeId=98de1306682a8, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518080, encodeId=8dda15180805e, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614164, encodeId=dc7d1614164ea, content=<a href='/topic/show?id=35fd506241c' target=_blank style='color:#2F92EE;'>#微泡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50624, encryptionId=35fd506241c, topicName=微泡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae519505912, createdName=124987cdm32暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620390, encodeId=814a16203908f, content=<a href='/topic/show?id=90c84034554' target=_blank style='color:#2F92EE;'>#噪声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40345, encryptionId=90c84034554, topicName=噪声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afc220104173, createdName=xinmeili, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000120, encodeId=2e84100012004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/3da0b4e87d244fc8964a8bc9c1f7d3b8/e4798d77bda342298fe093b744b40344.jpg, createdBy=e2623291388, createdName=Avigo, createdTime=Fri Jul 16 20:11:10 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047396, encodeId=e1d1104e3960e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 16 00:54:28 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999887, encodeId=e0fa99988e15, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Jul 15 23:12:19 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1750235, encodeId=47821e50235e1, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Nov 04 21:54:28 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809831, encodeId=e55c1809831c2, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Sat Apr 02 10:54:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034587, encodeId=ba89203458eed, content=<a href='/topic/show?id=195d83889d2' target=_blank style='color:#2F92EE;'>#胰岛素样生长因子-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83889, encryptionId=195d83889d2, topicName=胰岛素样生长因子-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Sep 19 05:54:28 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306682, encodeId=98de1306682a8, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518080, encodeId=8dda15180805e, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614164, encodeId=dc7d1614164ea, content=<a href='/topic/show?id=35fd506241c' target=_blank style='color:#2F92EE;'>#微泡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50624, encryptionId=35fd506241c, topicName=微泡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae519505912, createdName=124987cdm32暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620390, encodeId=814a16203908f, content=<a href='/topic/show?id=90c84034554' target=_blank style='color:#2F92EE;'>#噪声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40345, encryptionId=90c84034554, topicName=噪声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afc220104173, createdName=xinmeili, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000120, encodeId=2e84100012004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/3da0b4e87d244fc8964a8bc9c1f7d3b8/e4798d77bda342298fe093b744b40344.jpg, createdBy=e2623291388, createdName=Avigo, createdTime=Fri Jul 16 20:11:10 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047396, encodeId=e1d1104e3960e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 16 00:54:28 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999887, encodeId=e0fa99988e15, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Jul 15 23:12:19 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1750235, encodeId=47821e50235e1, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Nov 04 21:54:28 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809831, encodeId=e55c1809831c2, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Sat Apr 02 10:54:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034587, encodeId=ba89203458eed, content=<a href='/topic/show?id=195d83889d2' target=_blank style='color:#2F92EE;'>#胰岛素样生长因子-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83889, encryptionId=195d83889d2, topicName=胰岛素样生长因子-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Sep 19 05:54:28 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306682, encodeId=98de1306682a8, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518080, encodeId=8dda15180805e, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614164, encodeId=dc7d1614164ea, content=<a href='/topic/show?id=35fd506241c' target=_blank style='color:#2F92EE;'>#微泡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50624, encryptionId=35fd506241c, topicName=微泡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae519505912, createdName=124987cdm32暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620390, encodeId=814a16203908f, content=<a href='/topic/show?id=90c84034554' target=_blank style='color:#2F92EE;'>#噪声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40345, encryptionId=90c84034554, topicName=噪声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afc220104173, createdName=xinmeili, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000120, encodeId=2e84100012004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/3da0b4e87d244fc8964a8bc9c1f7d3b8/e4798d77bda342298fe093b744b40344.jpg, createdBy=e2623291388, createdName=Avigo, createdTime=Fri Jul 16 20:11:10 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047396, encodeId=e1d1104e3960e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 16 00:54:28 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999887, encodeId=e0fa99988e15, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Jul 15 23:12:19 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
    2021-07-17 ysjykql
  5. [GetPortalCommentsPageByObjectIdResponse(id=1750235, encodeId=47821e50235e1, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Nov 04 21:54:28 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809831, encodeId=e55c1809831c2, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Sat Apr 02 10:54:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034587, encodeId=ba89203458eed, content=<a href='/topic/show?id=195d83889d2' target=_blank style='color:#2F92EE;'>#胰岛素样生长因子-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83889, encryptionId=195d83889d2, topicName=胰岛素样生长因子-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Sep 19 05:54:28 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306682, encodeId=98de1306682a8, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518080, encodeId=8dda15180805e, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614164, encodeId=dc7d1614164ea, content=<a href='/topic/show?id=35fd506241c' target=_blank style='color:#2F92EE;'>#微泡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50624, encryptionId=35fd506241c, topicName=微泡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae519505912, createdName=124987cdm32暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620390, encodeId=814a16203908f, content=<a href='/topic/show?id=90c84034554' target=_blank style='color:#2F92EE;'>#噪声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40345, encryptionId=90c84034554, topicName=噪声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afc220104173, createdName=xinmeili, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000120, encodeId=2e84100012004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/3da0b4e87d244fc8964a8bc9c1f7d3b8/e4798d77bda342298fe093b744b40344.jpg, createdBy=e2623291388, createdName=Avigo, createdTime=Fri Jul 16 20:11:10 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047396, encodeId=e1d1104e3960e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 16 00:54:28 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999887, encodeId=e0fa99988e15, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Jul 15 23:12:19 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1750235, encodeId=47821e50235e1, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Nov 04 21:54:28 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809831, encodeId=e55c1809831c2, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Sat Apr 02 10:54:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034587, encodeId=ba89203458eed, content=<a href='/topic/show?id=195d83889d2' target=_blank style='color:#2F92EE;'>#胰岛素样生长因子-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83889, encryptionId=195d83889d2, topicName=胰岛素样生长因子-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Sep 19 05:54:28 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306682, encodeId=98de1306682a8, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518080, encodeId=8dda15180805e, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614164, encodeId=dc7d1614164ea, content=<a href='/topic/show?id=35fd506241c' target=_blank style='color:#2F92EE;'>#微泡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50624, encryptionId=35fd506241c, topicName=微泡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae519505912, createdName=124987cdm32暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620390, encodeId=814a16203908f, content=<a href='/topic/show?id=90c84034554' target=_blank style='color:#2F92EE;'>#噪声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40345, encryptionId=90c84034554, topicName=噪声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afc220104173, createdName=xinmeili, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000120, encodeId=2e84100012004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/3da0b4e87d244fc8964a8bc9c1f7d3b8/e4798d77bda342298fe093b744b40344.jpg, createdBy=e2623291388, createdName=Avigo, createdTime=Fri Jul 16 20:11:10 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047396, encodeId=e1d1104e3960e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 16 00:54:28 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999887, encodeId=e0fa99988e15, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Jul 15 23:12:19 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1750235, encodeId=47821e50235e1, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Nov 04 21:54:28 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809831, encodeId=e55c1809831c2, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Sat Apr 02 10:54:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034587, encodeId=ba89203458eed, content=<a href='/topic/show?id=195d83889d2' target=_blank style='color:#2F92EE;'>#胰岛素样生长因子-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83889, encryptionId=195d83889d2, topicName=胰岛素样生长因子-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Sep 19 05:54:28 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306682, encodeId=98de1306682a8, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518080, encodeId=8dda15180805e, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614164, encodeId=dc7d1614164ea, content=<a href='/topic/show?id=35fd506241c' target=_blank style='color:#2F92EE;'>#微泡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50624, encryptionId=35fd506241c, topicName=微泡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae519505912, createdName=124987cdm32暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620390, encodeId=814a16203908f, content=<a href='/topic/show?id=90c84034554' target=_blank style='color:#2F92EE;'>#噪声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40345, encryptionId=90c84034554, topicName=噪声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afc220104173, createdName=xinmeili, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000120, encodeId=2e84100012004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/3da0b4e87d244fc8964a8bc9c1f7d3b8/e4798d77bda342298fe093b744b40344.jpg, createdBy=e2623291388, createdName=Avigo, createdTime=Fri Jul 16 20:11:10 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047396, encodeId=e1d1104e3960e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 16 00:54:28 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999887, encodeId=e0fa99988e15, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Jul 15 23:12:19 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
    2021-07-17 xinmeili
  8. [GetPortalCommentsPageByObjectIdResponse(id=1750235, encodeId=47821e50235e1, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Nov 04 21:54:28 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809831, encodeId=e55c1809831c2, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Sat Apr 02 10:54:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034587, encodeId=ba89203458eed, content=<a href='/topic/show?id=195d83889d2' target=_blank style='color:#2F92EE;'>#胰岛素样生长因子-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83889, encryptionId=195d83889d2, topicName=胰岛素样生长因子-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Sep 19 05:54:28 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306682, encodeId=98de1306682a8, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518080, encodeId=8dda15180805e, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614164, encodeId=dc7d1614164ea, content=<a href='/topic/show?id=35fd506241c' target=_blank style='color:#2F92EE;'>#微泡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50624, encryptionId=35fd506241c, topicName=微泡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae519505912, createdName=124987cdm32暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620390, encodeId=814a16203908f, content=<a href='/topic/show?id=90c84034554' target=_blank style='color:#2F92EE;'>#噪声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40345, encryptionId=90c84034554, topicName=噪声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afc220104173, createdName=xinmeili, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000120, encodeId=2e84100012004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/3da0b4e87d244fc8964a8bc9c1f7d3b8/e4798d77bda342298fe093b744b40344.jpg, createdBy=e2623291388, createdName=Avigo, createdTime=Fri Jul 16 20:11:10 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047396, encodeId=e1d1104e3960e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 16 00:54:28 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999887, encodeId=e0fa99988e15, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Jul 15 23:12:19 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
    2021-07-16 Avigo

    学习学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1750235, encodeId=47821e50235e1, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Nov 04 21:54:28 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809831, encodeId=e55c1809831c2, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Sat Apr 02 10:54:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034587, encodeId=ba89203458eed, content=<a href='/topic/show?id=195d83889d2' target=_blank style='color:#2F92EE;'>#胰岛素样生长因子-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83889, encryptionId=195d83889d2, topicName=胰岛素样生长因子-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Sep 19 05:54:28 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306682, encodeId=98de1306682a8, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518080, encodeId=8dda15180805e, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614164, encodeId=dc7d1614164ea, content=<a href='/topic/show?id=35fd506241c' target=_blank style='color:#2F92EE;'>#微泡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50624, encryptionId=35fd506241c, topicName=微泡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae519505912, createdName=124987cdm32暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620390, encodeId=814a16203908f, content=<a href='/topic/show?id=90c84034554' target=_blank style='color:#2F92EE;'>#噪声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40345, encryptionId=90c84034554, topicName=噪声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afc220104173, createdName=xinmeili, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000120, encodeId=2e84100012004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/3da0b4e87d244fc8964a8bc9c1f7d3b8/e4798d77bda342298fe093b744b40344.jpg, createdBy=e2623291388, createdName=Avigo, createdTime=Fri Jul 16 20:11:10 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047396, encodeId=e1d1104e3960e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 16 00:54:28 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999887, encodeId=e0fa99988e15, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Jul 15 23:12:19 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
    2021-07-16 CHANGE

    疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1750235, encodeId=47821e50235e1, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Nov 04 21:54:28 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809831, encodeId=e55c1809831c2, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Sat Apr 02 10:54:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034587, encodeId=ba89203458eed, content=<a href='/topic/show?id=195d83889d2' target=_blank style='color:#2F92EE;'>#胰岛素样生长因子-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83889, encryptionId=195d83889d2, topicName=胰岛素样生长因子-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Sep 19 05:54:28 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306682, encodeId=98de1306682a8, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518080, encodeId=8dda15180805e, content=<a href='/topic/show?id=aa2269613cd' target=_blank style='color:#2F92EE;'>#生长因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69613, encryptionId=aa2269613cd, topicName=生长因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3df311117154, createdName=12499e01m50暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614164, encodeId=dc7d1614164ea, content=<a href='/topic/show?id=35fd506241c' target=_blank style='color:#2F92EE;'>#微泡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50624, encryptionId=35fd506241c, topicName=微泡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae519505912, createdName=124987cdm32暂无昵称, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620390, encodeId=814a16203908f, content=<a href='/topic/show?id=90c84034554' target=_blank style='color:#2F92EE;'>#噪声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40345, encryptionId=90c84034554, topicName=噪声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afc220104173, createdName=xinmeili, createdTime=Sat Jul 17 12:54:28 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000120, encodeId=2e84100012004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/3da0b4e87d244fc8964a8bc9c1f7d3b8/e4798d77bda342298fe093b744b40344.jpg, createdBy=e2623291388, createdName=Avigo, createdTime=Fri Jul 16 20:11:10 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047396, encodeId=e1d1104e3960e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 16 00:54:28 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999887, encodeId=e0fa99988e15, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Jul 15 23:12:19 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
    2021-07-15 SR~young海东

    关注医学

    0

相关资讯

盘点:近期鼻炎与治疗进展(八)

【1】Ann Allergy Asthma Immunol:SLIT片剂治疗过敏性鼻炎的进展分析

盘点:近期前列腺癌与治疗进展(八)

【1】Eur Urol Focus:前列腺癌局部治疗的候选患者研究

Eur Urol Focus:Siglec-6可作为膀胱癌患者新的潜在免疫检查点

膀胱癌(BCa)是一种高度流行的疾病,与大量的患病率、死亡率和每位病人的花费有关。尽管卡介苗(BCG)疗法是治疗非肌层浸润性膀胱癌的金标准,但这种疗法因其显著的副作用而受到限制,25%的患者因耐受性差

NEJM:多系统炎症综合征儿童的治疗比较

在接受单独的IVIG、IVIG加糖皮质激素或单独的糖皮质激素治疗后,对从MIS-C恢复并无不同,尽管随着累积更多的数据可能出现显著差异。

盘点:近期听力损失与治疗进展(八)

【1】Otol Neurotol:经皮骨传导植入物的长期和多中心结果

Stroke:COVID-19期间缺血性卒中患者的治疗和结局

与COVID-19之前的AIS患者相比,在COVID-19期间发生的AIS患者得到了相似质量的治疗,并且经历了类似的风险调整结局。这些结果表明,在COVID-19大流行期间,美国卒中治疗仍很稳健健。